Inovio Pharmaceuticals (INO) News Today → Biden replacement revealed? (From Paradigm Press) (Ad) Free INO Stock Alerts $10.57 +0.45 (+4.45%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineComparing Inovio Pharmaceuticals (NASDAQ:INO) and Atrion (NASDAQ:ATRI)americanbankingnews.com - April 27 at 1:16 AMPharmaJet’s needle-free delivery system proves effective in published studyfinance.yahoo.com - April 25 at 1:48 PMInovio Pharmaceuticals: The Dilution Continuesseekingalpha.com - April 25 at 1:48 PMGlobal COVID-19 Vaccines Research Report 2023-2025 - Licensing and Partnership Deals Worldwide Propel Vaccine Productionfinance.yahoo.com - April 22 at 7:52 AMInovio set to raise $36M following 'strategic refocus'bizjournals.com - April 16 at 5:04 PMInovio Announces Pricing Of About $36 Mln Offering Of Stock And Pre-Funded Warrants; Stock Dropsmarkets.businessinsider.com - April 15 at 9:02 PMINOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrantsprnewswire.com - April 15 at 6:39 PMInovio Pharmaceuticals (NASDAQ:INO) Rating Lowered to Sell at StockNews.commarketbeat.com - April 5 at 11:10 PMInovio Pharmaceuticals, Inc. (NASDAQ:INO) Sees Large Growth in Short Interestmarketbeat.com - April 2 at 7:37 AMINOVIO's Leadership to Spotlight Innovative Disease-Fighting Technologies at Citizens JMP Novel Therapeutics Forummsn.com - April 2 at 7:36 AMGlobal Human Vaccines Market (2023-2028)finance.yahoo.com - March 29 at 2:32 AMINOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicineprnewswire.com - March 26 at 6:28 PMInovio Pharmaceuticals, Inc. (NASDAQ:INO) Short Interest Up 6.9% in Februarymarketbeat.com - March 18 at 5:14 PMPeering Into Inovio Pharmaceuticals's Recent Short Interestbenzinga.com - March 11 at 2:01 PMBrokers Set Expectations for Inovio Pharmaceuticals, Inc.'s Q1 2024 Earnings (NASDAQ:INO)marketbeat.com - March 11 at 1:48 AMINO Mar 2024 6.500 callca.finance.yahoo.com - March 10 at 7:19 PMInovio Pharmaceuticals: Hold Rating with Promising Pipeline Despite Financial Lossesmarkets.businessinsider.com - March 7 at 1:56 PMInovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 7 at 1:56 PMInovio Pharmaceuticals (NASDAQ:INO) Given Sector Perform Rating at Royal Bank of Canadamarketbeat.com - March 7 at 10:32 AMQ4 2023 Inovio Pharmaceuticals Inc Earnings Callfinance.yahoo.com - March 7 at 8:56 AMInovio Pharmaceuticals (INO) Q4 2023 Earnings Call Transcriptfool.com - March 7 at 3:56 AMRecap: Inovio Pharmaceuticals Q4 Earningsbenzinga.com - March 6 at 9:53 PMPreview: Inovio Pharmaceuticals's Earningsbenzinga.com - March 6 at 4:53 PMInovio Pharmaceuticals Inc. Q4 Loss Narrowsmarkets.businessinsider.com - March 6 at 4:53 PMGeneos Therapeutics to Present New Clinical Data on GNOS-PV02 at the 2024 American Association for Cancer Research (AACR) Annual Meetingfinance.yahoo.com - March 6 at 4:53 PMINOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlightsfinance.yahoo.com - March 6 at 4:53 PMShort Interest in Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Rises By 21.7%marketbeat.com - March 3 at 5:57 PMInovio Pharmaceuticals (INO) Scheduled to Post Earnings on Wednesdaymarketbeat.com - February 28 at 3:05 AMInovio Pharmaceuticals (INO) Price Target Increased by 2590.47% to 19.21msn.com - February 24 at 8:00 AMNovavax’s dispute resolution and upcoming earnings call (INO)marketbeat.com - February 23 at 7:44 AMWall Street Analysts Predict a 146.39% Upside in Inovio (INO): Here's What You Should Knowfinance.yahoo.com - February 21 at 3:05 PMWall Street Analysts Predict a 146.39% Upside in Inovio (INO): Here's What You Should Knowfinance.yahoo.com - February 21 at 3:05 PMINOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024finance.yahoo.com - February 21 at 10:04 AMINOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024prnewswire.com - February 21 at 8:00 AMInovio Pharmaceuticals (NASDAQ:INO) Shares Pass Above 200 Day Moving Average of $5.60marketbeat.com - February 20 at 3:44 AMPenn’s BRCA cancer vaccine trial aims to prevent the disease in healthy peoplemsn.com - February 5 at 9:39 AMINOVIO Pharmaceuticals, Inc.: INOVIO Reports Inducement Grant Under Inducement Planfinanznachrichten.de - February 2 at 12:14 PMStockNews.com Downgrades Inovio Pharmaceuticals (NASDAQ:INO) to Sellmarketbeat.com - February 2 at 1:26 AMShort Interest in Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Declines By 5.8%marketbeat.com - January 31 at 10:24 AMHow Much Upside is Left in Inovio (INO)? Wall Street Analysts Think 223.72%finance.yahoo.com - January 30 at 6:02 PMInovio Pharmaceuticals Inc (0A43)uk.investing.com - January 28 at 8:30 AMInovio upgraded at Oppenheimer on rare disease therapymsn.com - January 25 at 7:55 PMmarketbeat.com - January 25 at 6:11 AMWhy Is Inovio Pharmaceuticals (INO) Stock Down Today?investorplace.com - January 24 at 10:12 AMINOVIO Pharmaceuticals, Inc.: INOVIO Announces Effective Date of 1-for-12 Reverse Stock Splitfinanznachrichten.de - January 23 at 12:36 PMINOVIO Announces Effective Date of 1-for-12 Reverse Stock Splitfinance.yahoo.com - January 23 at 12:36 PMInovio Pharma (INO) Stock Rallies 134% in a Month: Here's Whyfinance.yahoo.com - January 12 at 12:51 PMJMP Securities Initiates Coverage of Inovio Pharmaceuticals (INO) with Market Outperform Recommendationmsn.com - January 4 at 10:56 PMInovio Pharmaceuticals (NASDAQ:INO) Now Covered by Analysts at JMP Securitiesmarketbeat.com - January 4 at 8:22 AMINOVIO Plans To Submit BLA For INO-3107 In H2 - Quick Factsmarkets.businessinsider.com - January 3 at 10:43 AM Get Inovio Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for INO and its competitors with MarketBeat's FREE daily newsletter. Email Address Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached. Secure Your Spot Now INO Media Mentions By Week INO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INO News Sentiment▼-0.010.33▲Average Medical News Sentiment INO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INO Articles This Week▼52▲INO Articles Average Week Get Inovio Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for INO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Accuray News Utah Medical Products News AVITA Medical News Sight Sciences News Profound Medical News Alpha Tau Medical News AngioDynamics News Orchestra BioMed News Pulmonx News Quipt Home Medical News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INO) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressThe World's First "$20 Trillion Drug?"Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inovio Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
